Aspira Pathlab & Diagnostics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Aspira Pathlab & Diagnostics has a total shareholder equity of ₹101.4M and total debt of ₹27.8M, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are ₹147.1M and ₹45.7M respectively.
Anahtar bilgiler
27.4%
Borç/özkaynak oranı
₹27.82m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | ₹13.84m |
| Eşitlik | ₹101.43m |
| Toplam yükümlülükler | ₹45.66m |
| Toplam varlıklar | ₹147.10m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 540788's short term assets (₹43.6M) exceed its short term liabilities (₹20.7M).
Uzun Vadeli Yükümlülükler: 540788's short term assets (₹43.6M) exceed its long term liabilities (₹25.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 540788's net debt to equity ratio (13.8%) is considered satisfactory.
Borcun Azaltılması: 540788's debt to equity ratio has reduced from 130% to 27.4% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: Whilst unprofitable 540788 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Tahmini Nakit Akışı: 540788 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34% per year.